Invention Grant
- Patent Title: Crystalline forms of a pyridine derivative
- Patent Title (中): 吡啶衍生物的结晶形式
-
Application No.: US13056775Application Date: 2009-08-04
-
Publication No.: US08093242B2Publication Date: 2012-01-10
- Inventor: Clare Louise Anderton , Ronnie Maxwell Lawrence , David Clapham
- Applicant: Clare Louise Anderton , Ronnie Maxwell Lawrence , David Clapham
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent J. Scott Young
- Priority: GB0814340.6 20080805
- International Application: PCT/EP2009/060089 WO 20090804
- International Announcement: WO2010/015626 WO 20100211
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61K31/4985
Abstract:
The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
Public/Granted literature
- US20110136798A1 Crystalline Forms Of A Pyridine Derivative Public/Granted day:2011-06-09
Information query
